US Drug Recall Register
Class I · High risk Terminated Initiated May 11, 2022 (4 years ago)

Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only, Manufactured in India For…

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Failed Dissolution Specifications- Low Out-Of-Specification results obtained during stability testing.

What was recalled

Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only, Manufactured in India For: TEVA PHARMACEUTICALS USA, Inc., North Wales, PA 19454. NDC 0172-5241-60.

Recalling firm
Teva Pharmaceuticals USA Inc
NDC code
0172-5241-60
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0992-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Anagrelide recalls

See all